Impact of the erythropoiesis-stimulating agents (ESAS) risk evaluation and mitigation strategy (REMS) on ESA administration and red blood cell (RBC) transfusion for chemotherapy (CT) induced anemia (CIA)
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY（2018）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要